Patients with pacemaker or implantable cardioverter-defibrillator

Peter M Schulman1, Marc A Rozner, Valerie Sera

  • 1Department of Anesthesiology & Perioperative Medicine, Oregon Health & Science University, Mail Code: UHS-2, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239, USA.

Insights

Managing patients with cardiac implantable electronic devices (CIEDs) requires understanding device basics and following expert guidelines. Proper pre-procedure verification and management plans ensure safe perioperative care for these patients.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Biomedical Engineering

Background:

  • Cardiac implantable electronic devices (CIEDs) are increasingly common in surgical patients.
  • Perioperative management of CIEDs requires specialized knowledge beyond typical clinical practice.

Purpose of the Study:

  • To outline essential knowledge and systematic approaches for managing patients with CIEDs during the perioperative period.
  • To emphasize the importance of adhering to guidelines from professional societies.

Main Methods:

  • Review of current recommendations from the American Society of Anesthesiologists and Heart Rhythm Society.
  • Emphasis on understanding CIED indications, functions, operations, and limitations.
  • Highlighting the necessity of pre-procedure CIED function verification and obtaining specific device prescriptions.

Main Results:

  • Clinicians need a foundational understanding of CIEDs, regardless of their expertise level.
  • Systematic pre-procedure assessment and management planning are crucial for patient safety.
  • Adherence to established guidelines ensures competent care.

Conclusions:

  • Effective perioperative management of CIED patients relies on comprehensive knowledge and robust systems.
  • Safe and efficient care is achieved through diligent preparation and adherence to best practices.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
762
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
802
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
1.7K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
599
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
1.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812